A detailed history of Virtu Financial LLC transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 13,610 shares of COGT stock, worth $106,974. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,610
Holding current value
$106,974
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$8.24 - $11.48 $112,146 - $156,242
13,610 New
13,610 $147,000
Q4 2023

Feb 26, 2024

BUY
$4.06 - $10.08 $5,249 - $13,033
1,293 Added 10.51%
13,598 $80,000
Q3 2023

Nov 14, 2023

BUY
$9.69 - $13.34 $119,235 - $164,148
12,305 New
12,305 $120,000
Q2 2022

Aug 09, 2022

BUY
$3.92 - $9.73 $117,846 - $292,512
30,063 New
30,063 $271,000

Others Institutions Holding COGT

About Cogent Biosciences, Inc.


  • Ticker COGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,758,300
  • Market Cap $517M
  • Description
  • Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...
More about COGT
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.